Wnt3a can activate the extracellular signal regulated kinase (ERK) pathway through Ras, Raf, and mitogen-activated protein kinase (MEK), which are involved in cell proliferation and activate p38 and mitogen-activated protein kinase (MAPK), thereby promoting tumor progression (Yun et al., 2005). This evidence concerns the gene WNK2 and neoplasm.